Clinical Trials Directory

Trials / Unknown

UnknownNCT02234804

The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recross Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Aarhus University Hospital Skejby · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Prospective, controlled, double randomized, non-blinded, multicenter, investigator initiated, academic superiority trial comparing optical coherence tomography (OCT) guided vs. angiography guided wire recrossing in jailed side branches (SB) (1. randomization 1:1)(superiority) and comparing Medtronic Resolute Integrity and Xience Prime for stent strut apposition in the SB ostium (2. randomization 1:1) (superiority). Acute primary endpoint and 30 days clinical follow-up. Hypothesis: OCT guided wire recrossing in bifurcation stenting results in less malapposed struts in the segment facing the SB ostium. Secondary hypothesis: Treatment by Medtronic Resolute Integrity stent results in less malapposed struts at the bifurcation segment compared to treatment by the Abbott Xience Prime stent.

Detailed description

Purpose: To assess the ability of OCT to guide wire recrossing and reduce stent strut malapposition after kissing balloon dilatation. To compare stent strut apposition after treatment by two different stent designs using both guiding strategies of wire recrossing.

Conditions

Interventions

TypeNameDescription
DEVICEXience Prime Stent
DEVICEMedtronic Resolute Integrity stent
PROCEDUREAngiography
PROCEDUREOCT

Timeline

Start date
2013-07-01
Primary completion
2016-12-01
Completion
2017-02-01
First posted
2014-09-09
Last updated
2015-10-06

Locations

3 sites across 3 countries: Belgium, Denmark, United Kingdom

Source: ClinicalTrials.gov record NCT02234804. Inclusion in this directory is not an endorsement.